PureTech Health PLC (PRTC)
Industry Biotechnology
This stock can be held in an Investment ISA and an Investment Account
Sell
136.00p
Buy
136.20p
-0.40p (-0.29%)
PureTech Health PLC is a cross-disciplinary healthcare company developing products that could improve the lives of patients.
Prices updated at 30 May 2025, 16:35 BST
| Prices minimum 15 mins delay
|
Prices in GBX
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Income statement
Year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| 650,000 | 16m | 9m | 8m | 10m | 2m | 750,000 | 4m | |
| - | - | - | - | - | - | - | - | |
| -115m | -104m | -135m | -120m | -150m | -198m | -146m | -136m | |
| -17,756.92 | -635.39 | -1,558.46 | -1,433.05 | -1,506.00 | -9,464.40 | -19,493.47 | -3,154.00 | |
| 26m | -44m | 421m | 6m | -61m | -50m | -66m | 54m | |
| -68m | -65m | 488m | 29m | -47m | -80m | -18m | 37m | |
| Sales, General and administrative | 24m | 24m | 35m | 26m | 27m | 32m | 25m | 27m |
| Interest expenses | 704,000 | 392,000 | 3m | 3m | 5m | 4m | 13m | 10m |
| Provision for income taxes | 4m | 2m | 112m | 14m | 4m | -56m | 31m | -4m |
| Operating expenses | 116m | 120m | 144m | 128m | 160m | 200m | 147m | 140m |
| Income before taxes | -71m | -68m | 478m | 19m | -59m | -93m | -36m | 24m |
| Net income available to common shareholders | 26m | -44m | 421m | 6m | -61m | -50m | -66m | 54m |
| 0.13 | -0.16 | 1.49 | 0.02 | -0.21 | -0.18 | -0.24 | 0.21 | |
| Net interest income | -8m | 26m | 260,000 | -2m | -4m | 2m | 3m | 13m |
| Advertising and promotion | - | - | - | - | - | - | - | - |
| Net investment income, net | 169,000 | 137,000 | 68,000 | - | -56,000 | 14,000 | -94,000 | -25,000 |
| Realised capital gains (losses), net | - | - | - | - | - | - | - | - |
| Total benefits, claims and expenses | - | - | - | - | - | - | - | - |
| Earnings per share (diluted) | 0.13 | -0.16 | 1.44 | 0.02 | -0.21 | -0.18 | -0.24 | 0.21 |
| Free cash flow per share | -0.2433 | -0.284 | -0.216 | -0.2935 | -0.3773 | -0.5331 | -0.4412 | -0.3544 |
| Book value/share | 0.4324 | 0.8741 | 0.9359 | 2.0117 | 1.4623 | 1.7324 | 1.4841 | 1.0514 |
| Debt equity ratio | 0.001953 | 0.001296 | 0.052263 | 0.070035 | 0.072957 | 0.063441 | 0.039326 | 0.035377 |
Balance sheet
Year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Current assets | 198m | 260m | 169m | 414m | 502m | 386m | 347m | 386m |
| Current liabilities | 274m | 266m | 139m | 181m | 226m | 97m | 51m | 41m |
| Total capital | 214m | 276m | 668m | 685m | 608m | 552m | 464m | 415m |
| Total debt | 7m | 12m | 39m | 77m | 52m | 47m | 25m | 22m |
| Total equity | 214m | 276m | 668m | 670m | 594m | 542m | 464m | 415m |
| Total non current liabilities | - | - | - | - | - | - | - | - |
| Loans | - | - | - | 15m | 14m | 10m | - | - |
| Total assets | 340m | 442m | 941m | 990m | 946m | 703m | 694m | 603m |
| Total liabilities | - | - | - | - | - | - | - | - |
| Cash and cash equivalents | 73m | 117m | 132m | 404m | 466m | 150m | 191m | 281m |
| Common stock | 237m | 282m | 285m | 286m | 288m | 279m | 272m | 239m |
Cash flow
Year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash at beginning of period | 63m | 73m | 117m | 132m | 404m | 466m | 150m | 191m |
| Cash dividends paid | -91,000 | -1m | -112,000 | - | - | - | - | - |
| -91m | -77m | -111m | -137m | -164m | -181m | -106m | -134m | |
| Investments (gains) losses | 84m | -40m | 64m | 364m | 197m | -107m | 69m | 241m |
| 73m | 117m | 132m | 404m | 466m | 150m | 191m | 281m | |
| Net income | - | - | - | - | - | - | - | - |
| -89m | -73m | -98m | -132m | -158m | -179m | -106m | -134m | |
| -2m | -4m | -13m | -5m | -6m | -2m | -245,000 | -11,000 |
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.
